Login / Signup

Long-term efficacy and safety of leflunomide combined with low-dose prednisone in treatment of myasthenia gravis: a retrospective study.

Li QiuPei ChenChangyi OuJuan DengZhidong HuangZhongqiang LinQian MaXin HuangLu YuHao RanWeibin Liu
Published in: Acta neurologica Belgica (2023)
Long-term LEF + Pred therapy could considerably improve clinical symptoms in MG patients while being well tolerated with just few side effects.
Keyphrases
  • low dose
  • myasthenia gravis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • mesenchymal stem cells
  • depressive symptoms
  • replacement therapy
  • smoking cessation